SynthesisBMC public health2026
Determinants of human papillomavirus vaccination uptake in Nigeria: a mixed-methods systematic review.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) vaccination coverage in Nigeria is hindered by multiple barriers, including limited awareness, socioeconomic constraints, cultural beliefs, systemic challenges, and policy gaps. As a result, the burden of cervical cancer and other HPV-associated malignancies continues to rise despite public health interventions. The current mixed-methods systematic review (SR) synthesizes evidence on the determinants of HPV vaccination uptake in Nigeria to inform context-specific strategies for improving coverage.
methodsThe methodological procedures of this SR adhered to the Joanna Briggs Institute’s (JBI) guideline for systematic reviews and reported using PRISMA. A comprehensive systematic search of nine electronic databases was undertaken to identify peer-reviewed articles published from January 2015 to August 2025. After deduplication and screening of the retrieved literature, the methodological quality of the included studies was evaluated using the Mixed-Methods Appraisal Tool. Relevant data were extracted from all included articles and synthesized using a convergent integrated approach.
resultsAmong the 481 records identified, 16 studies involving 10,764 participants met the eligibility criteria. Most studies were conducted in southern Nigeria and focused on adolescents, students, parents, and caregivers. HPV vaccine acceptance ranged from 32.7% to 97.3%, yet actual uptake remained low at 1% to 15% in most studies. Limited knowledge and poor awareness were the most consistent determinants of low uptake. Other barriers included fear of side effects, misconceptions about infertility or sexual behavior, limited healthcare engagement, and lack of provider recommendation. Sociocultural influences such as parental approval, religious beliefs, and cultural norms also shaped vaccination decisions, while vaccine cost and limited availability further restricted uptake.
conclusionA significant gap exists between HPV vaccine acceptance and actual uptake in Nigeria. Improving coverage requires coordinated strategies that strengthen public education, address vaccine affordability, enhance provider communication, and respond to sociocultural concerns influencing vaccination decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.